Accessibility: Skip TopNav
Figure 1.
Individual cerebrospinal fluid (CSF) glucosylsphingosine (GluSph) log2-fold changes from baseline after 90 days of dosing with rexaceract
Format
PNG
Quelle:
Gain Therapeutics, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein